News Headline Summary

Eli Lilly's (LLY) Tabalumab receives orphan drug designation for multiple Myeloma treatment

Reaction details (19:05)

- Co. shares unreactive to the latest announcement, up 0.36% at USD 47.36 last.

21 Nov 2012 - 19:03 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: